Multimodal precision medicine
Integrating multi-omics, functional experiments and clinical information into interpretable patient-level models.
↗Based at the School of Biomedical Engineering and Technology, Tianjin Medical University, with active research links to Aalto University, we develop interpretable AI for precision medicine and drug discovery.
Integrating multi-omics, functional experiments and clinical information into interpretable patient-level models.
↗Developing cross-cohort methods for prognosis, disease stratification and treatment-response prediction.
↗Combining machine learning, molecular modeling, virtual screening and experimental validation to discover active molecules and combinations.
↗Weikaixin Kong is an Associate Professor and university-level recruited talent at the School of Biomedical Engineering and Technology, Tianjin Medical University, and a Postdoctoral Researcher in the Department of Computer Science at Aalto University. He earned his PhD from the University of Helsinki and his MSc and BSc from Peking University.
Academic profile ↗